Radius Pharmaceuticals
Specialty pharma (formerly Radius Health, taken private 2022)
Privately held: no public share price · United States
Assets
(1 total)
1Total Assets
1Approved
0Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | Estrogen receptorSmall molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer |
Upcoming events
(5 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (2)
2027 (1)
August 2027 (1)
ElacestrantPhase 1/2Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms, Breast Diseases, Central Nervous System Neoplasms, Brain Diseases …
Est. primary completion 2027-08 · NCT05386108 · CT.gov ↗
What to watch
2028 (1)
October 2028 (1)
Est. primary completion 2028-10 · NCT07766018 · CT.gov ↗
What to watch
2029 (1)
August 2029 (1)
Est. primary completion 2029-08 · NCT06492616 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.